[go: up one dir, main page]

GT199900197A - Formulaciones antiparasitarias. - Google Patents

Formulaciones antiparasitarias.

Info

Publication number
GT199900197A
GT199900197A GT199900197A GT199900197A GT199900197A GT 199900197 A GT199900197 A GT 199900197A GT 199900197 A GT199900197 A GT 199900197A GT 199900197 A GT199900197 A GT 199900197A GT 199900197 A GT199900197 A GT 199900197A
Authority
GT
Guatemala
Prior art keywords
formulations
antiparasitary
persons
endoparasites
milbemicines
Prior art date
Application number
GT199900197A
Other languages
English (en)
Inventor
Timothy Michael Lukas
Stephen Richard Wicks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199900197(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT199900197A publication Critical patent/GT199900197A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A FORMULACIONES ANTIPARASITARIAS Y, EN PARTICULAR, A FORMULACIONES ANTIPARASITARIAS QUE CONTIENEN AVERMECTINAS O MILBEMICINAS, INCLUYENDO DERIVADOS DE LAS MISMAS, QUE SON ADECUADAS PARA SU APLICACION TOPICA EN MAMIFEROS, PERSONAS Y ANIMALES DOMESTICOS COMO PERROS O GATOS INCLUIDOS, Y QUE SON UTILES EN EL TRATAMIENTO DE TRASTORNOS CAUSADOS POR ENDOPARASITOS O ECTOPARASITOS. SON DE ESPECIAL INTERES LAS FORMULACIONES DE SUBSTANCIAS ACTIVAS CONTRA PULGAS Y/O FILARIAS. DICHA FORMULACION ANTIPARASITARIA CONTIENE: (A) UN 0.150% P/V DE UNA AVERMECTINA O DE UNA MILBEMICINA QUE PRESENTA ACTIVIDAD CONTRA ENDOPARASITOS Y ECTOPARASITOS; (B) UN 150% V/V DE UN ETER MONOALQUILICO (C14) DE UN DIALQUILEN (C24) GLICOL; (C) UN ANTIOXIDANTE OPCIONAL; Y OPCIONALMENTE (D) UN DISOLVENTE VOLATIL Q. S. V/V, TOLERABLE POR LA PIEL.
GT199900197A 1998-11-19 1999-11-17 Formulaciones antiparasitarias. GT199900197A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825402.2A GB9825402D0 (en) 1998-11-19 1998-11-19 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
GT199900197A true GT199900197A (es) 2001-05-10

Family

ID=10842728

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900197A GT199900197A (es) 1998-11-19 1999-11-17 Formulaciones antiparasitarias.

Country Status (43)

Country Link
US (1) US6797701B2 (es)
EP (2) EP1522219B1 (es)
JP (1) JP3507799B2 (es)
KR (1) KR100458406B1 (es)
CN (1) CN1147232C (es)
AP (1) AP1210A (es)
AR (1) AR023062A1 (es)
AT (2) ATE288201T1 (es)
BG (1) BG65440B1 (es)
BR (1) BR9915458B1 (es)
CA (1) CA2351730C (es)
CO (1) CO5150175A1 (es)
CY (1) CY1111955T1 (es)
CZ (1) CZ304345B6 (es)
DE (2) DE69942465D1 (es)
DK (2) DK1522219T3 (es)
DZ (1) DZ2945A1 (es)
EA (1) EA003959B1 (es)
ES (2) ES2344505T3 (es)
GB (1) GB9825402D0 (es)
GT (1) GT199900197A (es)
HK (1) HK1040593B (es)
HR (1) HRP20010368B1 (es)
HU (1) HU229493B1 (es)
ID (1) ID28698A (es)
IL (3) IL142104A0 (es)
IS (1) IS5907A (es)
MA (1) MA25029A1 (es)
NO (1) NO20012389D0 (es)
NZ (2) NZ537110A (es)
OA (1) OA11678A (es)
PA (1) PA8485501A1 (es)
PE (1) PE20001319A1 (es)
PL (1) PL204763B1 (es)
PT (2) PT1522219E (es)
SI (2) SI1130966T2 (es)
SK (1) SK287540B6 (es)
TN (1) TNSN99213A1 (es)
TW (1) TW526045B (es)
UY (1) UY25806A1 (es)
WO (1) WO2000030449A1 (es)
YU (1) YU23401A (es)
ZA (1) ZA997174B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
WO2001020994A1 (en) * 1999-09-22 2001-03-29 Ashmont Holdings Limited Sheep pour-on
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
SK1282004A3 (en) 2001-09-17 2004-08-03 Lilly Co Eli Pesticidal formulations
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
GB2444572B (en) * 2006-12-05 2011-10-19 Michael Hilary Burke A process for the preparation of a stable anhydrous anthelmintic formulation
AU2010233409B2 (en) * 2009-02-16 2012-05-17 Zoetis Services Llc High dosage doramectin formulation
EP2416663A2 (en) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Parasiticidal formulation
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI1002174A2 (pt) * 2010-06-17 2012-03-13 Rotam Agrochem International Company Ltd Composição agroquímica, uso de um éter c2-c4 dialquileno glicol di-/mono-c1-c4 aquil, método para reduzir irritação ocular de formulações inseticidas líquidas, método de tratamento de praga em loco e uso da composição
KR20130044330A (ko) * 2010-07-30 2013-05-02 세바 상뜨 아니말르 사상충 체내 감염증을 조절하기 위한 조성물
WO2012054331A1 (en) * 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
IT1403631B1 (it) * 2011-01-14 2013-10-31 Gsi Geosyntec Invest B V Metodo e dispositivo per la posa e il tensionamento di una copertura impermeabile, per opere idrauliche in materiale sciolto.
BG1461U1 (bg) * 2011-03-18 2011-07-29 "Ендектовет" Еоод Състави за противопаразитно лекарствено средство
BRPI1104180A2 (pt) * 2011-08-25 2013-08-13 Eurofarma Lab Ltda composiÇÕes veterinÁrias pour on nço residuais, uso, kit, e mÉtodo de tratamento de parasitoses
EP2768513B8 (en) * 2011-10-18 2020-05-20 Institut national de recherche pour l'agriculture, l'alimentation et l'environnement Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
PL2785719T3 (pl) 2011-12-02 2018-03-30 Merial, Inc. Długodziałające wstrzykiwalne postaci moksydektyny i nowe postaci krystaliczne moksydektyny
CN109673653A (zh) * 2012-04-04 2019-04-26 先正达参股股份有限公司 杀有害生物剂组合物
AR094882A1 (es) 2013-02-26 2015-09-02 Zoetis Llc Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
HK1219623A1 (zh) * 2013-05-20 2017-04-13 Zoetis Services Llc 長效的螺環-異惡唑啉抗寄生蟲組合物
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
EP3595441B1 (en) 2017-03-17 2023-08-02 KRKA, d.d., Novo mesto Stable topical veterinary composition
KR20200090165A (ko) * 2017-11-23 2020-07-28 세바 상뜨 아니말르 기생충 감염 치료용 목시텍틴 함유 조성물
KR20250065422A (ko) 2017-12-15 2025-05-12 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
JPS4914624A (es) * 1972-06-08 1974-02-08
US3839234A (en) 1973-01-26 1974-10-01 C Roscoe Multi-purpose cleaning concentrate
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
GB2095107A (en) * 1981-03-24 1982-09-29 Janssen Pharmaceutica Nv Tetramisole-or levamisole pour-on compositions
EP0170006B1 (en) * 1984-06-05 1992-07-08 American Cyanamid Company Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
EP0192009B1 (fr) 1985-01-22 1991-09-04 Saint-Gobain Vitrage International Procédé de prèparation d'un poudre à base de formiate d'indium pour la formation d'une couche mince sur un substrat, notamment en verre.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3545529A1 (de) 1985-12-20 1987-07-02 Autotyp Sa Schneekette fuer fahrzeugraeder
LU86393A1 (fr) 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
EP0254583B1 (en) * 1986-07-24 1994-09-07 Beecham Group Plc Parasiticidal milbemycin derivatives, a process for their production, and compositions containing the same
BG48572A3 (bg) * 1987-01-23 1991-03-15 Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware Метод за получаване на авермектини
DE3727648A1 (de) † 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8807280D0 (en) * 1988-03-26 1988-04-27 Pfizer Ltd Antiparasitic agents
FR2630576B1 (fr) * 1988-04-26 1990-08-17 Realisations Nucleaires Et Dispositif d'amelioration de la duree de vie et de la fiabilite d'un tube neutronique scelle a haut flux
GB8815967D0 (en) 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
US4973468A (en) † 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
GB8917064D0 (en) * 1989-07-26 1989-09-13 Pfizer Ltd Antiparasitic agent
JP2978245B2 (ja) † 1990-03-05 1999-11-15 マリンクロット ベタリナリイ，インコーポレイテッド 寄生虫防除組成物ならびにその製造法および使用法
GB9121028D0 (en) 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5411737A (en) † 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
JP3966479B2 (ja) * 1993-04-16 2007-08-29 日本テキサス・インスツルメンツ株式会社 ゾルーゲル法による強誘電体膜の形成方法及びキャパシタの製造方法
ATE245900T1 (de) * 1993-05-10 2003-08-15 Merck & Co Inc Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
TW327125B (en) * 1994-02-07 1998-02-21 Merck & Co Inc Composition and method for protecting against pine exhausted
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
DE19520275A1 (de) † 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE69716880T2 (de) 1996-01-30 2003-07-17 Takeda Chemical Industries, Ltd. 1-arylpyrazole insektizide
DE19612644A1 (de) † 1996-03-29 1997-10-02 Bayer Ag Oxadiazin-Derivate
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
FI107528B (fi) 1998-12-23 2001-08-31 Kemira Chemicals Oy Menetelmä muurahaishapon valmistamiseksi

Also Published As

Publication number Publication date
AU5995999A (en) 2000-06-13
CY1111955T1 (el) 2015-11-04
SK6622001A3 (en) 2001-12-03
NZ537110A (en) 2006-04-28
ATE288201T1 (de) 2005-02-15
HRP20010368B1 (en) 2004-06-30
DE69923583D1 (de) 2005-03-10
IS5907A (is) 2001-03-23
PL348638A1 (en) 2002-06-03
US6797701B2 (en) 2004-09-28
CN1147232C (zh) 2004-04-28
KR100458406B1 (ko) 2004-11-26
CA2351730C (en) 2006-12-05
US20020028780A1 (en) 2002-03-07
EP1130966A1 (en) 2001-09-12
HRP20010368A2 (en) 2002-06-30
BG105601A (en) 2002-01-31
ZA997174B (en) 2001-05-18
TNSN99213A1 (fr) 2005-11-10
ID28698A (id) 2001-06-28
BR9915458A (pt) 2001-07-17
CO5150175A1 (es) 2002-04-29
DE69923583T2 (de) 2006-01-12
AP9901697A0 (en) 1999-12-31
PT1522219E (pt) 2010-07-19
EP1522219A1 (en) 2005-04-13
EP1130966B2 (en) 2009-05-27
PT1130966E (pt) 2005-04-29
DK1522219T3 (da) 2010-08-16
NO20012389L (no) 2001-05-15
PL204763B1 (pl) 2010-02-26
SK287540B6 (sk) 2011-01-04
HUP0104235A2 (hu) 2002-03-28
JP2002530302A (ja) 2002-09-17
CZ304345B6 (cs) 2014-03-19
JP3507799B2 (ja) 2004-03-15
ES2237213T3 (es) 2009-08-19
HUP0104235A3 (en) 2004-03-01
CN1326318A (zh) 2001-12-12
OA11678A (en) 2005-01-12
DE69942465D1 (de) 2010-07-15
BR9915458B1 (pt) 2011-04-19
HK1040593B (zh) 2004-10-08
SI1522219T1 (sl) 2010-09-30
HU229493B1 (en) 2014-01-28
NO20012389D0 (no) 2001-05-15
EA003959B1 (ru) 2003-10-30
SI1130966T1 (en) 2005-06-30
DK1130966T3 (da) 2005-05-09
ES2344505T3 (es) 2010-08-30
IL173567A0 (en) 2006-07-05
EP1130966B1 (en) 2005-02-02
WO2000030449A1 (en) 2000-06-02
AR023062A1 (es) 2002-09-04
EP1522219B1 (en) 2010-06-02
GB9825402D0 (en) 1999-01-13
CZ20011734A3 (cs) 2001-12-12
HK1040593A1 (en) 2002-06-21
SI1130966T2 (sl) 2009-08-31
TW526045B (en) 2003-04-01
MA25029A1 (fr) 2000-07-01
PA8485501A1 (es) 2000-09-29
NZ510678A (en) 2003-08-29
CA2351730A1 (en) 2000-06-02
DK1130966T4 (da) 2009-07-20
IL142104A (en) 2006-06-11
AU757892B2 (en) 2003-03-13
YU23401A (sh) 2005-06-10
AP1210A (en) 2003-09-30
PE20001319A1 (es) 2000-12-02
KR20010080505A (ko) 2001-08-22
UY25806A1 (es) 2001-08-27
BG65440B1 (bg) 2008-08-29
EA200100458A1 (ru) 2001-10-22
ATE469550T1 (de) 2010-06-15
DE69923583T3 (de) 2009-12-24
DZ2945A1 (fr) 2004-03-15
IL142104A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
GT199900197A (es) Formulaciones antiparasitarias.
ES2157601T3 (es) Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple.
BR9903100A (pt) Composição anidra, processo de tratamento não terapêutico da pele e/ou do couro cabeludo e utilização de um silicone oxialquilenado substituìdo em (-(
BR9907057A (pt) Composição perfumante antimicrobiana, artigo perfumado e utilização da composição.
BR9306564A (pt) Processo para o tratamento da epiderme de um mamífero terrestre sofrendo de uma condição constitída por uma função de barreira epidérmica perturbada
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
PT1112062E (pt) Composição para a administração tópica de ingredientes farmacêuticos activos
SG156624A1 (en) Organo-gel formulations for therapeutic applications
BRPI0512583A (pt) composições e métodos de produção das mesmas, de liberação de agente ativo para e através do tecido da epiderme de pessoa ou animal e de tratamento de paciente que sofre de onicomicose, de psorìase de unha e de infecções
AR013225A1 (es) Metodos y composiciones contra lineas finas y/o arrugas
PA8481401A1 (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino
ES2173978T3 (es) Utilizacion de un alcohol graso insaturado.
ES2181376T3 (es) Composicion cosmetica y/o dermatologica que contiene acido salicilico o un derivado del acido salicilico y su utilizacion.
AR024516A1 (es) Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica.
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
CR6306A (es) 1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
AR003984A1 (es) Composiciones antipruriticas, cosmeticas y/o farmaceuticas, procedimiento para su preparacion y empleo de dichas composiciones para la obtencion de unmedicamento.
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
PT1073467E (pt) Formulacoes de co-solvente que compreendem um composo de vitamina d.
BR0307494A (pt) Composição que contêm extrato de palha de aveia e de erva de salgueiro
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
AR001790A1 (es) Formulaciones para parches transdermicos que sirven para el tratamiento de condiciones modeladas de receptores muscarinicos